Risk Factors for the Development of Brain Metastases in Patients With HER2-positive Breast Cancer

ESMO Open - United Kingdom
doi 10.1136/esmoopen-2018-000440
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer
Cancer ResearchOncology
2012English

Development of a Risk Scoring System for Evaluating the Prognosis of Patients With Her2-Positive Breast Cancer

Cancer Cell International
Cancer ResearchOncologyGenetics
2020English

Risk Factors for Breast Cancer Brain Metastases: A Systematic Review

Oncotarget
Oncology
2020English

Risk Factors for Brain Metastases in Patients With Renal Cell Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Radio-Sensitising Effect of T-Dm1 Should Not Be Discarded for the Efficacy of Radiosurgery in the Management of Brain Metastases in Patients With HER2-positive Metastatic Breast Cancer

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy

AboutOpen
2018English

Phase I Study of Intermittent High Dose Lapatinib Alternating With Capecitabine for HER2-positive Breast Cancer Patients With Central Nervous System Metastases

Clinical Cancer Research
Cancer ResearchOncology
2019English

Internodal HER2 Heterogeneity of Axillary Lymph Node Metastases in Breast Cancer Patients

Bosnian Journal of Basic Medical Sciences
Medicine
2019English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy